RESMED INC
For the period ended Mar 31, 2024. Filed Apr 26, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 26, 2024
RMD$234.11-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Equity (Unaudited)
| PART I – FINANCIAL INFORMATION | Item 1 |
|---|
Condensed Consolidated Statements of Changes in Equity (Unaudited)
| Common Stock · AdditionalPaid-in Capital · Treasury Stock · RetainedEarnings · AccumulatedOtherComprehensive Income (Loss) · Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | ||||||||||
| Balance, June 30, 2023 | 188,901 | $588 | $1,772,083 | (41,836) | $(1,623,256) | $4,253,016 | $(272,528) | $4,129,903 | ||
| Common stock issued on exercise of options | 17 | — | 983 | — | — | — | — | 983 | ||
| Common stock issued on vesting of restricted stock units, net of shares withheld for tax | 3 | — | (225) | — | — | — | — | (225) | ||
| Stock-based compensation costs | — | — | 18,510 | — | — | — | — | 18,510 | ||
| Other comprehensive loss | — | — | — | — | — | — | (47,620) | (47,620) | ||
| Net income | — | — | — | — | — | 219,422 | — | 219,422 | ||
| Dividends declared ($0.48 per common share) | — | — | — | — | — | (70,597) | — | (70,597) | ||
| Balance, September 30, 2023 | 188,921 | $588 | $1,791,351 | (41,836) | $(1,623,256) | $4,401,841 | $(320,148) | $4,250,376 | ||
| Common stock issued on exercise of options | 24 | — | 1,557 | — | — | — | — | 1,557 | ||
| Common stock issued on vesting of restricted stock units, net of shares withheld for tax | 163 | 1 | (7,798) | — | — | — | — | (7,797) | ||
| Common stock issued on employee stock purchase plan | 151 | 1 | 17,966 | — | — | — | — | 17,967 | ||
| Treasury stock purchases | — | (2) | 2 | (336) | (50,007) | — | — | (50,007) | ||
| Stock-based compensation costs | — | — | 19,840 | — | — | — | — | 19,840 | ||
| Other comprehensive income | — | — | — | — | — | — | 111,796 | 111,796 | ||
| Net income | — | — | — | — | — | 208,800 | — | 208,800 | ||
| Dividends declared ($0.48 per common share) | — | — | — | — | — | (70,678) | — | (70,678) | ||
| Balance, December 31, 2023 | 189,259 | $588 | $1,822,918 | (42,172) | $(1,673,263) | $4,539,963 | $(208,352) | $4,481,854 | ||
| Common stock issued on exercise of options | 54 | — | 4,679 | — | — | — | — | 4,679 | ||
| Common stock issued on vesting of restricted stock units, net of shares withheld for tax | 6 | — | (314) | — | — | — | — | (314) | ||
| Stock-based compensation costs | — | — | 20,442 | — | — | — | — | 20,442 | ||
| Common stock issued on employee stock purchase plan | — | — | 213 | — | — | — | — | 213 | ||
| Treasury stock purchases | — | — | — | (260) | (50,000) | — | — | (50,000) | ||
| Other comprehensive loss | — | — | — | — | — | (56,954) | (56,954) | |||
| Net income | — | — | — | — | — | 300,492 | — | 300,492 | ||
| Dividends declared ($0.48 per common share) | — | — | — | — | — | (70,492) | — | (70,492) | ||
| Balance, March 31, 2024 | 189,319 | $588 | $1,847,938 | (42,432) | $(1,723,263) | $4,769,963 | $(265,306) | $4,629,920 | ||
| PART I – FINANCIAL INFORMATION | Item 1 |
|---|
Condensed Consolidated Statements of Changes in Equity (Unaudited)
| Common Stock · AdditionalPaid-inCapital · Treasury Stock · RetainedEarnings · AccumulatedOtherComprehensive Income (Loss) · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | ||||||||
| Balance, June 30, 2022 | 188,247 | $586 | $1,682,432 | (41,836) | $(1,623,256) | $3,613,736 | $(312,747) | $3,360,751 |
| Common stock issued on exercise of options | 45 | — | 2,610 | — | — | — | — | 2,610 |
| Common stock issued on vesting of restricted stock units, net of shares withheld for tax | 3 | — | (59) | — | — | — | — | (59) |
| Stock-based compensation costs | — | — | 16,919 | — | — | — | — | 16,919 |
| Other comprehensive loss | — | — | — | — | — | — | (93,381) | (93,381) |
| Net income | — | — | — | — | — | 210,478 | — | 210,478 |
| Dividends declared ($0.44 per common share) | — | — | — | — | — | (64,431) | — | (64,431) |
| Balance, September 30, 2022 | 188,295 | $586 | $1,701,902 | (41,836) | $(1,623,256) | $3,759,783 | $(406,128) | $3,432,887 |
| Common stock issued on exercise of options | 77 | — | 5,120 | — | — | — | — | 5,120 |
| Common stock issued on vesting of restricted stock units, net of shares withheld for tax | 265 | 1 | (29,655) | — | — | — | — | (29,654) |
| Common stock issued on employee stock purchase plan | 100 | 1 | 16,935 | — | — | — | — | 16,936 |
| Stock-based compensation costs | — | — | 16,464 | — | — | — | — | 16,464 |
| Other comprehensive income | — | — | — | — | — | — | 135,960 | 135,960 |
| Net income | — | — | — | — | — | 224,914 | — | 224,914 |
| Dividends declared ($0.44 per common share) | — | — | — | — | — | (64,500) | — | (64,500) |
| Balance, December 31, 2022 | 188,737 | $588 | $1,710,766 | (41,836) | $(1,623,256) | $3,920,197 | $(270,168) | $3,738,127 |
| Common stock issued on exercise of options | 18 | — | 983 | — | — | — | — | 983 |
| Common stock issued on vesting of restricted stock units, net of shares withheld for tax | 6 | — | (584) | — | — | — | — | (584) |
| Stock-based compensation costs | — | — | 17,832 | — | — | — | — | 17,832 |
| Other comprehensive income | — | — | — | — | — | — | 8,291 | 8,291 |
| Net income | — | — | — | — | — | 232,500 | — | 232,500 |
| Dividends declared ($0.44 per common share) | — | — | — | — | — | (64,640) | — | (64,640) |
| Balance, March 31, 2023 | 188,761 | $588 | $1,728,997 | (41,836) | $(1,623,256) | $4,088,057 | $(261,877) | $3,932,509 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.